Search
cefditoren (Spectracef)
Tradename: Spectracef. (cefditoren pivoxil)
Indications:
- bacterial infection due to susceptible organisms
a) bronchitis (patients 12 & older)
b) pneumonia
c) pharyngitis (tonsillitis)
d) uncomplicated skin infections
Dosage:
1) 400 mg PO BID for 10 days (bronchitis)
2) 200 mg PO BID for 10 days (skin infections, pharyngitis)
Tabs: 200 mg
Pharmacokinetics:
-> presumably metabolized in liver
Antimicrobial activity:
- Streptococcus
- Streptococcus pneumoniae
- Streptococcus pyogenes
- Haemophilus influenzae
- Haemophilus parainfluenzae
- Moraxella catarrhalis
- Staphylococcus aureus
Adverse effects:
-> one of its metabolites increases renal excretion of carnitine
Notes: Manufacturer: TAP pharmaceuticals
Interactions
drug interactions
drug adverse effects of cephalosporins
Related
carnitine (Carnitor)
General
cephalosporin, 3rd generation
Properties
MISC-INFO: elimination route LIVER
Database Correlations
PUBCHEM correlations
References
- Prescriber's Letter 8(10):59 2001
- Deprecated Reference